id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-266456-10tjzqep	Sadeghipour, Parham	Management of ST‐segment‐elevation myocardial infarction during the coronavirus disease 2019 (COVID‐19) outbreak: Iranian“247” National Committee's position paper on primary percutaneous coronary intervention	2020-04-22		.txt	text/plain	1438	102	47	title: Management of ST‐segment‐elevation myocardial infarction during the coronavirus disease 2019 (COVID‐19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary intervention Such safety concerns, along with the acceptable mortality benefit of the new generation of fibrinolytic agents, have placed thrombolytic therapy as a potential first choice on several occasions during the outbreak. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum Management of ST-segment-elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) outbreak: Iranian"247" National Committee's position paper on primary percutaneous coronary intervention	./cache/cord-266456-10tjzqep.txt	./txt/cord-266456-10tjzqep.txt